Home » Topics » Regulatory

Regulatory
RSS

Regeneron's Eylea receives second U.S. approval

Sep. 27, 2012

FDA approves denosumab in new indication

Sep. 25, 2012

FDA approves production of [11C]-choline injection for PET imaging

Sep. 14, 2012

FDA approves Genzyme's MS therapeutic

Sep. 13, 2012

FDA approves Pfizer's bosutinib for CML

Sep. 5, 2012

Teduglutide receives European marketing authorization for short bowel syndrome

Sep. 5, 2012

FDA approves Xtandi for metastatic castration-resistant prostate cancer

Sep. 3, 2012

New drug approved for IBS-C and CIC

Aug. 31, 2012

Nucynta ER approved for new indication in U.S.

Aug. 30, 2012

European Commission approves Zinforo

Aug. 29, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 13, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 13, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
Science in 2025: the best of the rest
BioWorld Science
A review of 2025's noteworthy advances in medical research, including GLP-1 receptor agonists as anti-aging drugs, tumor-agnostic therapies and xenotransplants.
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...